AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio’s 15th Stem Cell Summit – PR Newswire (press release)
PR Newswire (press release) |
AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio’s 15th Stem Cell Summit
PR Newswire (press release) Dr. Keirstead’s talk is titled “Clinical and Commercial Application of Scaled Human Stem Cell Derivates.” “I’m honored to be included in a faculty with so many other longstanding colleagues in the field,” said Dr. Keirstead. “Stem cell-based treatments … |
Northwestern University NewsCenter |
New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold
Northwestern University NewsCenter I’m excited to see where it goes. The study builds on Tullman-Ercek’s earlier work, which found that a single amino acid mutation in the same MS2 bacteriophage scaffold drastically changed its size. Tullman-Ercek serves as a faculty member within … |
Motley Fool |
This Little-Known Company Should Have Gilead’s and Celgene’s Investors Nervous
Motley Fool With Gilead Sciences (NASDAQ:GILD) acquiring Kite Pharmaceuticals and Celgene (NASDAQ:CELG) buying Juno Therapeutics to gain access to their chimeric antigen receptor T cell (CAR T) cancer immunotherapies, you’d think the biggest competition would be … |